Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AVTX

Avalo Therapeutics Inc

May 08 • 04:00PM ET

21.57

-1.30 -5.68 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: ZURA COGT AUPH KYTX ARQT

| Held by: VTI VXF ITOT IWC TMSL DFAS DFMC TMED BMED DXUV

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.10	Insider Own	10.04%	Shs Outstand	26.71M	Perf Week	57.33%
Market Cap	576.23M	Forward P/E	-	EPS next Y	-4.03	Insider Trans	-10.30%	Shs Float	24.05M	Perf Month	51.79%
Enterprise Value	480.29M	PEG	-	EPS next Q	-1.03	Inst Own	72.20%	Short Float	21.78%	Perf Quarter	52.01%
Income	-78.26M	P/S	9603.85	EPS this Y	39.48%	Inst Trans	44.67%	Short Ratio	4.33	Perf Half Y	31.12%
Sales	0.06M	P/B	4.81	EPS next Y	-14.08%	ROA	-58.31%	Short Interest	5.24M	Perf YTD	18.78%
Book/sh	4.49	P/C	5.86	EPS next 5Y	14.19%	ROE	-72.43%	52W High	24.27 -11.12%	Perf Year	395.86%
Cash/sh	3.68	P/FCF	-	EPS past 3/5Y	82.35% 70.20%	ROIC	-91.98%	52W Low	3.39 536.28%	Perf 3Y	-96.60%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-85.16% -61.19%	Gross Margin	-483.05%	Volatility	15.96% 9.87%	Perf 5Y	-99.72%
Dividend TTM	-	EV/Sales	8004.85	EPS Y/Y TTM	95.62%	Oper. Margin	-123601.69%	ATR (14)	1.81	Perf 10Y	-99.80%
Dividend Ex-Date	-	Quick Ratio	8.14	Sales Y/Y TTM	-86.62%	Profit Margin	-132642.37%	RSI (14)	71.07	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.14	EPS Q/Q	78.04%	SMA20	41.24%	Beta	0.83	Target Price	46.90
Payout	-	Debt/Eq	0.03	Sales Q/Q	-69.27%	SMA50	38.78%	Rel Volume	1.46	Prev Close	22.87
Employees	33	LT Debt/Eq	0.02	Earnings	Mar 23 BMO	SMA200	48.07%	Avg Volume	1.21M	Price	21.57
IPO	Nov 13, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	47.48% -	Trades		Volume	1,767,329	Change	-5.68%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)